Angptl4 mRNA expression was highly associated with ccRCC (p = 1.5 10−49, Chi square test) allowing to define its expression as a diagnosis marker for primary ccRCC.
Nevertheless, further investigations are needed to define its expression and function, and to determine its relationship, if any, to WNT4.
Therefore, we used lacZ expression from the linc Brn1b locus in heterozygote mutants to define its expression in vivo.
For example, in RNA secondary structure phenotypes, genotype networks are typically highly fragmented [ 18, 27], whereas for regulatory circuits, such fragmentation depends on the kind of circuit studied, its size, and how one defines its gene expression phenotypes [ 7, 8, 28].
VCAM-MPIO detected VCAM-1 expression and defined its 3-dimensional distribution, revealing 'ischemic memory' in mouse kidneys.
(1) VCAM-MPIO detected VCAM-1 expression and defined its 3-dimensional distribution, revealing "ischemic memory" in renal IRI; (2) automated volumetric quantification of VCAM-MPIO accurately reflected tissue levels of VCAM-1 mRNA; and (3) VCAM-MPIO bound rapidly to target with active sequestration of unbound MPIO in the liver and spleen.
This B cell subset is defined by its expression of FcRL4, and expresses significantly higher levels of mRNA for RANKL and TNF-α compared to other synovial B cells.
In addition, we include the evaluation of ER-α immunocytofluorescence to define its pattern of expression in feline mammary cancer cells, detecting different levels of positivity, but generally low or weak (60% of immunopositivity).
Note that the extent of Ubx function in the abdomen is defined by its expression pattern.
At least three additional subsets of cells can be identified in the nasal epithelium [4] [6], [11], [12], including a subset that is defined by its expression of the olfactory-specific guanylyl cyclase (GC-D) [13], [14].
